Zynex receives fda clearance of cm-1600 monitor for improved blood and fluid management

Englewood, colo. , june 20, 2023 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the fda (food and drug administration) has granted 510(k) market clearance for the company's cm-1600 blood and fluid volume monitoring device.
ZYXI Ratings Summary
ZYXI Quant Ranking